Asato Hashinokuchi

Asato Hashinokuchi

Auto-generated profile, based on publicly available information

Asato Hashinokuchi

Department of Thoracic Oncology , NHO Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1347

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2024 in Chest
Verified
Journal Article
Closed access
Shinkichi TakamoriShinkichi Takamori
Shinkichi Takamori
AOAtsushi Osoegawa
Atsushi Osoegawa
AHAsato Hashinokuchi
Asato Hashinokuchi
TKTakashi Karashima
Takashi Karashima
YTYohei Takumi
Yohei Takumi
TKTakefumi Komiya
Takefumi Komiya

20 December 2024 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
AHAsato Hashinokuchi
Asato Hashinokuchi
TATakaki Akamine
Takaki Akamine
GTGouji Toyokawa
Gouji Toyokawa
KMKyoto Matsudo
Kyoto Matsudo
TNTaichi Nagano
Taichi Nagano
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
OBJECTIVES: Spread through air spaces (STAS) is considered a poor prognostic factor in patients with resected non-small lung cell cancer; however, the clinical significance of STAS extent remains unclear. We hypothesized that the further the tumour cells spread from the tumour edge, the worse the prognosis becomes. METHODS: This study retrospectively reviewed the data of 642 patients with completely resected pathological stage I–III non-small lung cell cancer between 2008 and 2018. The maximum spread distance (MSD) from the tumour edge to the farthest STAS was quantitatively evaluated, and STAS was categorized as limited (MSD ≤1000 μm) or extended (MSD >1000 μm), based on the median MSD. Recurrence-free survival (RFS) and overall survival (OS) were compared among patients stratified by STAS classification. RESULTS: Patients were classified into STAS-negative (n = 382, 59.6%), limited STAS (n = 130, 20.2%) and extended STAS (n = 130, 20.2%) groups. Extended STAS was associated with a high maximum standardized uptake value, advanced pathological stage and vascular invasion compared with limited STAS. The extended STAS group demonstrated significantly shorter RFS and OS than both the limited STAS and STAS-negative groups (both P < 0.001 for RFS; P = 0.007 and P < 0.001 for OS, respectively). Multivariable analysis showed that extended STAS was an independent prognostic factor for both RFS and OS (P < 0.001, P < 0.001, respectively). CONCLUSIONS: The distance from tumour edge to STAS affects prognosis in patients with completely resected non-small lung cell cancer. Clinical registration number: IRB approval number: 2019-232

12 August 2022 in Thoracic Cancer
Verified
Journal Article
Open access
AHAsato Hashinokuchi
Asato Hashinokuchi
NHNaoki Haratake
Naoki Haratake
TTTomoyoshi Takenaka
Tomoyoshi Takenaka
KMKyoto Matsudo
Kyoto Matsudo
TNTaichi Nagano
Taichi Nagano
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
Background: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in early‐stage lung adenocarcinoma is not well known.Methods: We retrospectively evaluated the relationship between the combination of SUVmax and CEA and the prognosis of 410 patients with clinical stage IA lung adenocarcinoma who underwent resection. The cutoff values for SUVmax and CEA were determined by receiver operating characteristic curve analysis, and patients were categorized into high SC (SUVmax and CEA) group (SUVmax ≥2.96 and CEA ≥5.3), moderate SC group (either SUVmax <2.96 and CEA ≥5.3 or SUVmax ≥2.96 and CEA <5.3) and low SC group (SUVmax <2.96 and CEA <5.3).Results: Kaplan–Meier curve analysis showed that patients with clinical stage IA lung adenocarcinoma in the high SC group had significantly shorter overall survival (OS) and recurrence‐free survival (RFS) than the other groups (p = 0.011 and p < 0.0001, respectively). Multivariate analysis showed that high SC was an independent prognostic factor of OS (p = 0.029) and RFS (p < 0.0001).Conclusions: High values of SUVmax and CEA were associated with poor OS and RFS in patients with stage IA lung adenocarcinoma. Simultaneous evaluation of SUVmax and CEA may be an effective prognostic marker to determine the optimal treatment strategy of early‐stage lung adenocarcinoma.

18 August 2026 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Closed access
AHAsato Hashinokuchi
Asato Hashinokuchi
KKKeisuke Kosai
Keisuke Kosai
NHNaoki Haratake
Naoki Haratake
TFTakatoshi Fujishita
Takatoshi Fujishita
SSShinichiro Shimamatsu
Shinichiro Shimamatsu
MYMasafumi Yamaguchi
Masafumi Yamaguchi
Objectives: Spread through air spaces (STAS) is a poor prognostic pathological feature recently included as a histological factor in the ninth edition of the TNM (tumor, node, and metastasis) classification. However, its clinical significance in lung adenocarcinoma with epidermal growth factor receptor (EGFR) gene mutations remains unclear. Here, we aimed to evaluate the clinical significance of STAS according to EGFR mutation status. Methods: We retrospectively reviewed 347 patients with completely resected pathological stage 0–IIIB lung adenocarcinoma who were evaluated for both STAS and EGFR mutations between 2015 and 2022. We investigated the association between clinicopathological features and STAS and analyzed its prognostic relevance based on EGFR mutation status. Results: STAS and EGFR mutations were present in 85 (24.5%) and 178 (51.3%) patients, respectively. In patients with EGFR-mutated lung adenocarcinoma, STAS was significantly more prevalent in those with exon 19 deletions than those with the L858R mutation (P = .012). STAS was significantly markedly associated with poorer recurrence-free and overall survival in patients both with (P < .001 and P < .001, respectively) and without (P = .003 and P = .023, respectively) EGFR mutations. Multivariable analysis revealed that STAS was an independent prognostic factor for recurrence-free and overall survival in patients with EGFR mutations (P < .001 and P = .020, respectively). However, STAS was not an independent predictor in patients without EGFR mutations. Conclusions: STAS is a key pathological feature of lung adenocarcinoma and holds considerable clinical relevance, particularly in EGFR-mutated lung adenocarcinoma.

1 December 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
STSaori Tou
Saori Tou
KMKoutarou Matsumoto
Koutarou Matsumoto
AHAsato Hashinokuchi
Asato Hashinokuchi
FKFumihiko Kinoshita
Fumihiko Kinoshita
YNYasunobu Nohara
Yasunobu Nohara
MKMasahiro Kamouchi
Masahiro Kamouchi
Background: Prolonged hospital stays can lead to inefficiencies in health care delivery and unnecessary consumption of medical resources. Objective: This study aimed to identify key clinical variances associated with prolonged length of stay (PLOS) in clinical pathways using a machine learning model trained on real-world data from the ePath system. Methods: We analyzed data from 480 patients with lung cancer (age: mean 68.3, SD 11.2 years; n=263, 54.8% men) who underwent video-assisted thoracoscopic surgery at a university hospital between 2019 and 2023. PLOS was defined as a hospital stay exceeding 9 days after video-assisted thoracoscopic surgery. The variables collected between admission and 4 days after surgery were examined, and those that showed a significant association with PLOS in univariate analyses (P<.01) were selected as predictors. Predictive models were developed using sparse linear regression methods (Lasso, ridge, and elastic net) and decision tree ensembles (random forest and extreme gradient boosting). The data were divided into derivation (earlier study period) and testing (later period) cohorts for temporal validation. The model performance was assessed using the area under the receiver operating characteristic curve, Brier score, and calibration plots. Counterfactual analysis was used to identify key clinical factors influencing PLOS. Results: A 3D heatmap illustrated the temporal relationships between clinical factors and PLOS based on patient demographics, comorbidities, functional status, surgical details, care processes, medications, and variances recorded from admission to 4 days after surgery. Among the 5 algorithms evaluated, the ridge regression model demonstrated the best performance in terms of both discrimination and calibration. Specifically, it achieved area under the receiver operating characteristic curve values of 0.84 and 0.82 and Brier scores of 0.16 and 0.17 in the derivation and test cohorts, respectively. In the final model, a range of variables, including blood tests, care, patient background, procedures, and clinical variances, were associated with PLOS. Among these, particular emphasis was placed on clinical variances. Counterfactual analysis using the ridge regression model identified 6 key variables strongly linked to PLOS. In order of impact, these were abnormal respiratory sounds, postoperative fever, arrhythmia, impaired ambulation, complications after drain removal, and pulmonary air leaks. Conclusions: A machine learning–based model using ePath data effectively identified critical variances in the clinical pathways associated with PLOS. This automated tool may enhance clinical decision-making and improve patient management.

29 March 2025 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
AHAsato Hashinokuchi
Asato Hashinokuchi
TATakaki Akamine
Takaki Akamine
TTTomoyoshi Takenaka
Tomoyoshi Takenaka
TYTomoharu Yoshizumi
Tomoharu Yoshizumi